DexCom (Brazil) Today
| D1EX34 Stock | BRL 8.65 0.11 1.26% |
Performance4 of 100
| Odds Of DistressLess than 9
|
DexCom is trading at 8.65 as of the 25th of November 2024, a 1.26% down since the beginning of the trading day. The stock's open price was 8.76. DexCom has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for DexCom Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California. The company has 4.84 B outstanding shares. More on DexCom Inc
Moving against DexCom Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
DexCom Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. DexCom's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding DexCom or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Diagnostics & Research, Healthcare (View all Sectors) |
DexCom Inc (D1EX34) is traded on Sao Paulo Exchange in Brazil and employs 5,500 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 280.7 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate DexCom's market, we take the total number of its shares issued and multiply it by DexCom's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. DexCom Inc operates under Healthcare sector and is part of Diagnostics & Research industry. The entity has 4.84 B outstanding shares.
DexCom Inc has accumulated about 2.58 B in cash with 409 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 26.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check DexCom Probability Of Bankruptcy
DexCom Inc Risk Profiles
Although DexCom's alpha and beta are two of the key measurements used to evaluate DexCom's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.7 | |||
| Semi Deviation | 2.36 | |||
| Standard Deviation | 2.66 | |||
| Variance | 7.05 |
DexCom Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in DexCom without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Additional Information and Resources on Investing in DexCom Stock
When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..